Patient, n | 21 |
LA roof-dependent atrial tachycardia, n | 22 |
Age, years | 73.0 (58.5–80.5) |
Male gender, n (%) | 12 (57.1%) |
Concomitant AF, n (%) | 20 (95.2%) |
Structural heart disease, n (%) | 5 (23.8%) |
Hypertrophic cardiomyopathy, n | 1 |
Dilated cardiomyopathy, n | 1 |
Cardiac sarcoidosis, n | 1 |
Cardiac surgery, n (%) | 2 (9.5%) |
Mitral valve repair, n | 1 |
Aortic and mitral valve repair, n | 1 |
Sick sinus syndrome, n (%) | 4 (19.0%) |
AV conduction disturbance, n (%) | 1 (4.8%) |
Left atrial diameter, mm | 42.6 ± 6.4 |
Left ventricular ejection fraction, % | 58.8 ± 14.4 |
Brain natriuretic peptide, pg/ml | 89.1 [48.0–157.0] |
Antiarrhythmic drugs before procedure, n (%) | 7 (31.8%) |
Flecainide 100 mg/day, n | 1 |
Propafenone 300 mg/day, n | 1 |
Bepridil 100 mg/day, n | 2 |
Amiodarone 100 mg/day, n | 3 |